World Biosimilars Congress 2012, 11-13 September, London, UK

Date: May-15-2012Strategies for navigating the regulatory, manufacturing, sales and marketing route to biosimilar market entry.

11 - 13 September 2012, Jumeirah Carlton Tower, London, UK

Get competitive insight into global regulatory strategies, and find out how to successfully bring biosimilars to-market in developed and developing regions. With leading companies from India, Israel, Switzerland, UK, USA, Germany and more speaking at the World Biosimilars Congress, this is a great opportunity to get a complete overview of the development pathway for biosimilars in your region of interest, and find out which other lucrative markets you should be targeting.
Compare regulatory pathways for biosimilars in developed and developing markets
Get critical insight on to-market models from Teva and Sandoz in the EU and US, and beyond
Debate the minimum level of clinical testing required for a safe and approvable product
Consider the best options for product selection based on market analysis and competitive landscape
Find out how to design a patent-dispute pathway to avoid IP infringement
Understand how to demonstrate biosimilarity with comparability to the reference product
Ensure that immunogenicity standards are kept seamless from development to in-clinic
Learn about new frontiers in cell line development and the opportunities for biosimilar manufacture
Find out how to improve bioprocessing and production of biosimilars
Network with regulators, drug manufacturers and service providers to assess and secure new partners

Visit our website for full list of speakers and programe.

Download the brochure for more information.

To book your place contact: Marcia Ardila on email: marcia.ardila@terrapinn.com or register your place online at http://www.terrapinn.com/2012/biosimilars-congress

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.